Anti-inflammatory effects of formoterol and ipratropium bromide against acute cadmium-induced pulmonary inflammation in rats

European Journal of Pharmacology

Volumn 628, Issue 1-3, 2010, Pages 171-178

  Zhang, Wenhui ^a   Fievez, Laurence ^b   Cheu, Esteban ^b   Bureau, Fabrice ^b   Rong, Weifang ^a   Zhang, Fan ^a   Zhang, Yong ^a   Advenier, Charles ^c   Gustin, Pascal ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UPRES EA 220   (France)

Author keywords

Cadmium; Formoterol; Ipratropium bromide; Matrix metalloproteinase; Pulmonary inflammation

Indexed keywords

BRONCHODILATING AGENT; CADMIUM; FORMOTEROL; GELATINASE A; GELATINASE B; ILOMASTAT; IPRATROPIUM BROMIDE; PROPRANOLOL;

AIRWAY RESISTANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; INFLAMMATORY CELL; LUNG CONGESTION; LUNG EDEMA; LUNG PARENCHYMA; MACROPHAGE; MALE; MONOTHERAPY; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT;

EID: 73649091049     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.11.015     Document Type: Article

References (54)

1. Abboud R.T., and Vimalanathan S. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Int. J. Tuberc. Lung Dis. 12 (2008) 361-367
2. Anelli T., Mannello F., Salani M., Tonti G.A., Poiana G., and Biagioni S. Acetylcholine induces neurite outgrowth and modulates matrix metalloproteinase 2 and 9. Biochem. Biophys. Res. Commun. 362 (2007) 269-274
3. Antonicelli F., Brown D., Parmentier M., Drost E.M., Hirani N., Rahman I., Donaldson K., and MacNee W. Regulation of LPS-mediated inflammation in vivo and in vitro by the thiol antioxidant Nacystelyn. Am. J. Physiol. Lung Cell Mol. Physiol. 286 (2004) L1319-1327
4. Asano K., Shikama Y., Shibuya Y., Nakajima H., Kanai K., Yamada N., and Suzaki H. Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro. Int. J. Chron. Obstruct. Pulmon. Dis. 3 (2008) 781-789
5. Bolognin M., Kirschvink N., Leemans J., De Buscher V., Snaps F., Gustin P., Peeters D., and Clercx C. Characterisation of the acute and reversible airway inflammation induced by cadmium chloride inhalation in healthy dogs and evaluation of the effects of salbutamol and prednisolone. Vet. J. 179 (2009) 443-450
6. Bos I.S., Gosens R., Zuidhof A.B., Schaafsma D., Halayko A.J., Meurs H., and Zaagsma J. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur. Respir. J. 30 (2007) 653-661
7. Bowden J.J., Sulakvelidze I., and McDonald D.M. Inhibition of neutrophil and eosinophil adhesion to venules of rat trachea by beta 2-adrenergic agonist formoterol. J. Appl. Physiol. 77 (1994) 397-405
8. Churg A., Wang R.D., Tai H., Wang X., Xie C., Dai J., Shapiro S.D., and Wright J.L. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. Am. J. Respir. Crit. Care Med. 167 (2003) 1083-1089
9. Ciencewicki J., Trivedi S., and Kleeberger S.R. Oxidants and the pathogenesis of lung diseases. J. Allergy Clin. Immunol. 122 (2008) 456-468 quiz 469-470
10. Corbel M., Boichot E., and Lagente V. Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury. Braz. J. Med. Biol. Res. 33 (2000) 749-754
11. Corbel M., Lagente V., Theret N., Germain N., Clement B., and Boichot E. Comparative effects of betamethasone, cyclosporin and nedocromil sodium in acute pulmonary inflammation and metalloproteinase activities in bronchoalveolar lavage fluid from mice exposed to lipopolysaccharide. Pulm. Pharmacol. Ther. 12 (1999) 165-171
12. Cui Y.Y., Zhu L., Wang H., Advenier C., Chen H.Z., and Devillier P. Muscarinic receptors involved in airway vascular leakage induced by experimental gastro-oesophageal reflux. Life Sci. 82 (2008) 949-955
13. de Oliveira Martins J., Meyer-Pflug A.R., Alba-Loureiro T.C., Melbostad H., Costa da Cruz J.W., Coimbra R., Curi R., and Sannomiya P. Modulation of lipopolysaccharide-induced acute lung inflammation: role of insulin. Shock 25 (2006) 260-266
14. Delaunois A., Gustin P., and Ansay M. Altered capillary filtration coefficient in parathion- and paraoxon-induced edema in isolated and perfused rabbit lungs. Toxicol. Appl. Pharmacol. 116 (1992) 161-169
15. Delaunois A., Gustin P., and Ansay M. Modulation of the acetylcholine- and substance P-induced pulmonary edema by calcitonin gene-related peptide in the rabbit. J. Pharmacol. Exp. Ther. 270 (1994) 30-36
16. Dhingra V.K., Uusaro A., Holmes C.L., and Walley K.R. Attenuation of lung inflammation by adrenergic agonists in murine acute lung injury. Anesthesiology 95 (2001) 947-953
17. Donohue J.F. Combination therapy for chronic obstructive pulmonary disease: clinical aspects. Proc. Am. Thorac. Soc. 2 (2005) 272-281
18. Fligiel S.E., Standiford T., Fligiel H.M., Tashkin D., Strieter R.M., Warner R.L., Johnson K.J., and Varani J. Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury. Hum. Pathol. 37 (2006) 422-430
19. Gavett S.H., and Oberdorster G. Cadmium chloride and cadmium metallothionein-induced pulmonary injury and recruitment of polymorphonuclear leukocytes. Exp. Lung Res. 20 (1994) 517-537
20. Gipson T.S., Bless N.M., Shanley T.P., Crouch L.D., Bleavins M.R., Younkin E.M., Sarma V., Gibbs D.F., Tefera W., McConnell P.C., Mueller W.T., Johnson K.J., and Ward P.A. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury. J. Immunol. 162 (1999) 3653-3662
21. Gosens R., Zaagsma J., Meurs H., and Halayko A.J. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir. Res. 7 (2006) 73
22. Gwilt C.R., Donnelly L.E., and Rogers D.F. The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation?. Pharmacol. Ther. 115 (2007) 208-222
23. Hanania N.A., and Moore R.H. Anti-inflammatory activities of beta2-agonists. Curr. Drug Targets Inflamm. Allergy 3 (2004) 271-277
24. Hogg J.C. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364 (2004) 709-721
25. Inoue H., Aizawa H., Matsumoto K., Shigyo M., Takata S., Hara M., and Hara N. Effect of beta 2-agonists on histamine-induced airway microvascular leakage in ozone-exposed guinea pigs. Am. J. Respir. Crit. Care Med. 156 (1997) 723-727
26. Johnson M. Effects of beta2-agonists on resident and infiltrating inflammatory cells. J. Allergy Clin. Immunol. 110 (2002) S282-S290
27. Keck T., Balcom J.H.t., Fernandez-del Castillo C., Antoniu B.A., and Warshaw A.L. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology 122 (2002) 188-201
28. Kim J.H., Suk M.H., Yoon D.W., Lee S.H., Hur G.Y., Jung K.H., Jeong H.C., Lee S.Y., Suh I.B., Shin C., Shim J.J., In K.H., Yoo S.H., and Kang K.H. Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 291 (2006) L580-L587
29. Kirschvink N., Leemans J., Delvaux F., Snaps F., Clercx C., and Gustin P. Non-invasive assessment of airway responsiveness in healthy and allergen-sensitised cats by use of barometric whole body plethysmography. Vet. J. 173 (2007) 343-352
30. Kirschvink N., Vincke G., Fievez L., Onclinx C., Wirth D., Belleflamme M., Louis R., Cataldo D., Peck M.J., and Gustin P. Repeated cadmium nebulizations induce pulmonary MMP-2 and MMP-9 production and emphysema in rats. Toxicology 211 (2005) 36-48
31. LaCroix C., Freeling J., Giles A., Wess J., and Li Y.F. Deficiency of M2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress. Am. J. Physiol. Heart Circ. Physiol. 294 (2008) H810-H820
32. Ma S., Lin Y.Y., Tartell L., and Turino G.M. The effect of tiotropium therapy on markers of elastin degradation in COPD. Respir. Res. 10 (2009) 12
33. Maneechotesuwan K., Essilfie-Quaye S., Meah S., Kelly C., Kharitonov S.A., Adcock I.M., and Barnes P.J. Formoterol attenuates neutrophilic airway inflammation in asthma. Chest 128 (2005) 1936-1942
34. Mannino D.M., Holguin F., Greves H.M., Savage-Brown A., Stock A.L., and Jones R.L. Urinary cadmium levels predict lower lung function in current and former smokers: data from the Third National Health and Nutrition Examination Survey. Thorax 59 (2004) 194-198
35. Maris N.A., van der Sluijs K.F., Florquin S., de Vos A.F., Pater J.M., Jansen H.M., and van der Poll T. Salmeterol, a beta2-receptor agonist, attenuates lipopolysaccharide-induced lung inflammation in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 286 (2004) L1122-L1128
36. McQueen D.S., Donaldson K., Bond S.M., McNeilly J.D., Newman S., Barton N.J., and Duffin R. Bilateral vagotomy or atropine pre-treatment reduces experimental diesel-soot induced lung inflammation. Toxicol. Appl. Pharmacol. 219 (2007) 62-71
37. Menon B., Singh M., and Singh K. Matrix metalloproteinases mediate beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes. Am. J. Physiol Cell Physiol. 289 (2005) C168-C176
38. Miyamoto M., Tomaki M., Lotvall J., and Linden A. Beta-adrenoceptor stimulation and neutrophil accumulation in mouse airways. Eur. Respir. J. 24 (2004) 231-237
39. Patiyal S.N., and Katoch S.S. Beta-adrenoceptor agonist clenbuterol down-regulates matrix metalloproteinase (MMP-9) and results in an impairment of collagen turnover in mice left ventricle. Jpn. J. Physiol. 55 (2005) 165-172
40. Profita M., Giorgi R.D., Sala A., Bonanno A., Riccobono L., Mirabella F., Gjomarkaj M., Bonsignore G., Bousquet J., and Vignola A.M. Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy 60 (2005) 1361-1369
41. Proskocil B.J., and Fryer A.D. Beta2-agonist and anticholinergic drugs in the treatment of lung disease. Proc. Am. Thorac. Soc. 2 (2005) 305-310 discussion 311-302
42. Qiu Y., Zhu J., Bandi V., Atmar R.L., Hattotuwa K., Guntupalli K.K., and Jeffery P.K. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 168 (2003) 968-975
43. Razani-Boroujerdi S., Behl M., Hahn F.F., Pena-Philippides J.C., Hutt J., and Sopori M.L. Role of muscarinic receptors in the regulation of immune and inflammatory responses. J. Neuroimmunol. 194 (2008) 83-88
44. Reinheimer T., Baumgartner D., Hohle K.D., Racke K., and Wessler I. Acetylcholine via muscarinic receptors inhibits histamine release from human isolated bronchi. Am. J. Respir. Crit. Care Med. 156 (1997) 389-395
45. Ricou B., Nicod L., Lacraz S., Welgus H.G., Suter P.M., and Dayer J.M. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154 (1996) 346-352
46. Sato E., Koyama S., Okubo Y., Kubo K., and Sekiguchi M. Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. Am. J. Physiol. 274 (1998) L970-L979
47. Senzaki H., Paolocci N., Gluzband Y.A., Lindsey M.L., Janicki J.S., Crow M.T., and Kass D.A. beta-blockade prevents sustained metalloproteinase activation and diastolic stiffening induced by angiotensin II combined with evolving cardiac dysfunction. Circ. Res. 86 (2000) 807-815
48. Tetley T.D. Inflammatory cells and chronic obstructive pulmonary disease. Curr. Drug Targets Inflamm. Allergy 4 (2005) 607-618
49. Tokuyama K., Lotvall J.O., Lofdahl C.G., Barnes P.J., and Chung K.F. Inhaled formoterol inhibits histamine-induced airflow obstruction and airway microvascular leakage. Eur. J. Pharmacol. 193 (1991) 35-39
50. Watson N., Reddy H., and Eglen R.M. Characterization of muscarinic receptor and beta-adrenoceptor interactions in guinea-pig oesophageal muscularis mucosae. Eur. J. Pharmacol. 294 (1995) 779-785
51. Wessler I., Holper B., Kortsik C., Buhl R., Kilbinger H., and Kirkpatrick C.J. Dysfunctional inhibitory muscarinic receptors mediate enhanced histamine release in isolated human bronchi. Life Sci. 80 (2007) 2294-2297
52. Whelan C.J., Johnson M., and Vardey C.J. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung. Br. J. Pharmacol. 110 (1993) 613-618
53. Wirth D., Bureau F., Melotte D., Christians E., and Gustin P. Evidence for a role of heat shock factor 1 in inhibition of NF-kappaB pathway during heat shock response-mediated lung protection. Am. J. Physiol. Lung Cell Mol. Physiol. 287 (2004) L953-L961
54. Yeh C.C., Kao S.J., Lin C.C., Wang S.D., Liu C.J., and Kao S.T. The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sci. 80 (2007) 1821-1831